Company page

Advicenne Sa

Advicenne Sa is a public company listed on the French market under the ticker ALDVI, with a market capitalization of approximately €26.98 million. The company focuses on developing innovative treatments for rare kidney diseases. Its commitment to addressing unmet medical needs positions it as a key player in the healthcare sector.